| 257.58 -3.12 (-1.2%) | 01-16 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |   |
|||
| Targets | 6-month : | 307.03 | 1-year : | 358.61 |
| Resists | First : | 262.86 | Second : | 307.03 |
| Pivot price | 250.18 |
|||
| Supports | First : | 248.73 | Second : | 240 |
| MAs | MA(5) : | 258.05 |
MA(20) : | 248.8 |
| MA(100) : | 259.99 |
MA(250) : | 251.42 |
|
| MACD | MACD : | 2.3 |
Signal : | 0.6 |
| %K %D | K(14,3) : | 84.2 |
D(3) : | 82.3 |
| RSI | RSI(14): 59.5 |
|||
| 52-week | High : | 293.8 | Low : | 199.91 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ RMD ] has closed below upper band by 21.1%. Bollinger Bands are 40.4% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 0 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 261.35 - 262.72 | 262.72 - 263.89 |
| Low: | 253.7 - 255.27 | 255.27 - 256.61 |
| Close: | 255.01 - 257.67 | 257.67 - 259.92 |
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME)to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; and HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies. The company markets its products primarily to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
Mon, 19 Jan 2026
QRG Capital Management Inc. Sells 63,696 Shares of ResMed Inc. $RMD - MarketBeat
Mon, 19 Jan 2026
ResMed Inc (NYSE:RMD) S&P 500 Chart Maps Long-Term Medical Presence - Kalkine Media
Mon, 19 Jan 2026
ResMed Inc. (NYSE:RMD) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Fri, 16 Jan 2026
ResMed Inc. (NYSE:RMD) Embodies Quality Investing Principles - Chartmill
Wed, 14 Jan 2026
Nordea Investment Management AB Acquires 26,629 Shares of ResMed Inc. $RMD - MarketBeat
Wed, 14 Jan 2026
Reflecting On Patient Monitoring Stocks' Q3 Earnings: ResMed (NYSE:RMD) - Finviz
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Outperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Instruments & Supplies
|
|
| Shares Out | 146 (M) |
| Shares Float | 145 (M) |
| Held by Insiders | 0.5 (%) |
| Held by Institutions | 65.5 (%) |
| Shares Short | 10,560 (K) |
| Shares Short P.Month | 10,650 (K) |
| EPS | 9.77 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 41.93 |
| Profit Margin | 27.3 % |
| Operating Margin | 34.6 % |
| Return on Assets (ttm) | 14.1 % |
| Return on Equity (ttm) | 25.4 % |
| Qtrly Rev. Growth | 9.1 % |
| Gross Profit (p.s.) | 21.85 |
| Sales Per Share | 36.03 |
| EBITDA (p.s.) | 13.29 |
| Qtrly Earnings Growth | 12.3 % |
| Operating Cash Flow | 1,880 (M) |
| Levered Free Cash Flow | 1,380 (M) |
| PE Ratio | 26.36 |
| PEG Ratio | 0 |
| Price to Book value | 6.14 |
| Price to Sales | 7.14 |
| Price to Cash Flow | 19.99 |
| Dividend | 0.6 |
| Forward Dividend | 0 |
| Dividend Yield | 0.2% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|